Quarter 2026/Q2
| Line item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 |
|---|---|---|---|---|---|
| Net Common Stock Issuance | -$25.03M | -$20.00M | -$19.14M | -$12.25M | -$5.11M |
| -Change in Other Current Liabilities | -$4.32M | -$4.07M | -$1.59M | -$4.75M | -$2.26M |
| -Change in Other Current Assets | -$1.29M | $6.76M | -$1.11M | -$15.13M | $4.04M |
| -Change in Payables and Accrued Expense | $13.57M | -$8.37M | $1.80M | -$8.58M | -$26.96M |
| -Change in Inventory | $752,000.00 | -$776,000.00 | -$2.12M | -$1.94M | $315,000.00 |
| -Change in Receivables | -$23.30M | -$904,000.00 | -$27.35M | $10.07M | -$4.71M |
| Change in Working Capital | -$14.62M | -$5.40M | -$31.51M | -$19.60M | -$29.86M |
| Other Non-Cash Items | $1.13M | $1.16M | $2.89M | $1.70M | $1.69M |
| Deferred Tax | $3.41M | $2.79M | $11.26M | $34.39M | -$6.88M |
| Depreciation & Depletion & Amortization | $12.83M | $12.82M | $11.65M | $12.16M | $11.46M |
| Gain/Loss from Continuing Operations | $4.56M | $6.29M | -$922,000.00 | -$2.52M | $1.14M |
| Net Income from Continuing Operations | $24.21M | $23.38M | $34.60M | $35.10M | $34.22M |
| Net cash flow from continuing operations | $41.89M | $50.64M | $35.93M | $70.63M | $22.72M |
| Operating Cash Flow | $41.89M | $50.64M | $35.93M | $70.63M | $22.72M |
| -Change In Other Working Capital | -$29,000.00 | $1.96M | -$1.15M | $722,000.00 | -$283,000.00 |
| Net cash flow from investing | -$23.12M | $2.41M | -$108.48M | -$17.02M | -$177.81M |
| Proceeds from Stock Option Exercised | $43,000.00 | $2.06M | $1.04M | $1.13M | $731,000.00 |
| Net Other Financing Charges | -$11.79M | -$300,000.00 | -$15.43M | -$750,000.00 | – |
| Ending Cash Balance | $485.54M | $503.58M | $968.81M | $1.07B | $1.03B |
| Net Change in Cash | -$18.00M | -$465.20M | -$106.09M | $41.74M | -$161.21M |
| Beginning Cash Balance | $503.58M | $968.81M | $1.07B | $1.03B | $1.19B |
| Effect of Exchange Rate Changes | -$37,000.00 | -$36,000.00 | -$6,000.00 | $23,000.00 | -$66,000.00 |
| Free Cash Flow | $36.71M | $49.51M | $34.79M | $65.60M | $17.81M |
| Net Issuance Payments Of Debt | $0.00 | -$500.00M | $0.00 | $0.00 | $0.00 |
| Net Cash Flow from Continuing Financing Activities | -$36.77M | -$518.24M | -$33.54M | -$11.88M | -$6.12M |
| Financing Cash Flow | -$36.77M | -$518.24M | -$33.54M | -$11.88M | -$6.12M |
| Net Business Purchase and Sale | -$15.08M | $4.95M | -$104.95M | -$12.68M | -$170.93M |
| Net PPE Purchase and Sale | -$4.85M | -$912,000.00 | -$860,000.00 | -$4.75M | -$4.55M |
| Capital Expenditure | -$326,000.00 | -$212,000.00 | -$275,000.00 | -$274,000.00 | -$350,000.00 |
| Net Cash Flow from Continuing Investing Activities | -$23.12M | $2.41M | -$108.48M | -$17.02M | -$177.81M |
| Net Other Investing Changes | -$2.86M | -$1.42M | -$938,000.00 | -$768,000.00 | -$1.98M |
| Net Intangibles Purchase and Sale | – | – | $0.00 | – | – |
No comments yet — be the first to weigh in on ALRM.